Dr. Vandewalker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 W Nifong Blvd
Suite 2b
Columbia, MO 65203Phone+1 573-446-7000Fax+1 573-445-1000- Is this information wrong?
Summary
- I am a BC allergist in specialty practice for almost 40 years in mid-Missouri. In addition to part-time employment with Family Allergy and Asthma of Louisville, I serve as Medical Director for Clinical Research of the Ozarks. We have conducted over 500 clinical trials of new allergy and asthma drugs during three decades. I teach outpatient allergy/asthma management skills to medical students and residents who rotate through my office. I consult and speak for several pharma companies and have been privileged to serve my specialty in leadership at state and national levels. I plan to fund a research grant in Allergy/Immunology at St Louis U. School of Medicine, my alma mater.
Education & Training
- Fitzsimons Army Medical CenterFellowship, Allergy and Immunology, 1983 - 1985
- Fitzsimons Army Medical CenterResidency, Pediatrics, 1978 - 1981
- Saint Louis University School of MedicineClass of 1978
Certifications & Licensure
- MO State Medical License 1985 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow, American College of Allergy, Asthma, and Immunology ACAAI, 1986
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- 43 citationsSafety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trialElianne J.L.E. Vrijlandt, Georges El Azzi, Mark Vandewalker, Ned Rupp, Thomas Harper, LeRoy Graham, Stanley J. Szefler, Petra Moroni-Zentgraf, Ashish Sharma, Sebastian...> ;The Lancet. Respiratory Medicine. 2018 Feb 1
- 76 citationsTiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and alle...Huib A. M. Kerstjens, Petra Moroni-Zentgraf, Donald P. Tashkin, Ronald Dahl, Pierluigi Paggiaro, Mark Vandewalker, Hendrik Schmidt, Michael Engel, Eric D. Bateman> ;Respiratory Medicine. 2016 Aug 1
- 78 citationsTiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging studyChristian Vogelberg, Michael Engel, Petra Moroni-Zentgraf, Migle Leonaviciute-Klimantaviciene, Ralf Sigmund, John Downie, Katja Nething, Viktorija Vevere, Mark Vandewa...> ;Respiratory Medicine. 2014 Sep 1
- Join now to see all
Press Mentions
- New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype1,2,3March 8th, 2016
Research History
- Medical Director/Principal InvestigatorI have conducted over 500 FDA-reviewed clinical trials involving allergic rhinitis, asthma, allergic conjunctivitis, chronic urticaria, COPD, and pharmacokinetic studies.1990 - Present
Professional Memberships
- Fellow
- Fellow
- Hal Nelson Society of Military AllergistsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: